Personally, I think OPT is a better bet than MSB. We could well see a capital raising (CR) or we might secure funding through a partnership with a major global company. After grappling with the knowledge that a dilution event is very likely to occur in the next 2-3 months, I decided anyway to invest the limit of my 'at risk' capital allocation now. It would certainly hurt if it hit 0 cents, so while accepting the risk, I expect I may take some money off the table in 2024 or early 2025, depending on how things progress
Opthea shares target raised on trial progress, page-11
Add OPT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.082(18.3%) |
Mkt cap ! $241.9M | |||
| Open | High | Low | Value | Volume |
| 39.0¢ | 39.0¢ | 36.5¢ | $2.219M | 5.914M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 8 | 531084 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 73885 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
36.5¢ |
Change
-0.082 ( 17.5 %) |
||||
| Open | High | Low | Volume | ||
| 39.3¢ | 39.3¢ | 36.5¢ | 1925987 | ||
| Last updated 15.58pm 14/06/2024 ? | |||||
| OPT (ASX) Chart |